(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

FIBLECTEV

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: United States

Quick snapshot

FIBLECTEV

ST13

US500000088404153

Class

5

Filing

88404153

Registration

6976516

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

46

Latest update

07/23/2026

Trademark type

Word

Nice classes

5

Filing date

04/26/2019

Registration date

02/14/2023

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

02/14/2023

Last transaction

07/23/2026

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

Filing basis

Intent to use, Foreign priority

Drawing code

4

Owner type

99

Owner location

Carrigtohill Co. Cork,, IE

Examiner

MACIOL II, EUGENE VALENTINE-JO

Law office

L30

Current location

PUBLICATION AND ISSUE SECTION

Holders and representatives

Holders

G. U. (pessoa física)
G. U. (pessoa física)

Representatives

Shelley Lai Gilead Sciences, Inc.

Technical classification

Nice Classes

Class 5

Vienna Codes

No Vienna codes available.

Goods and services

Class 5

Antiviral pharmaceutical preparations; anti-infective pharmaceutical preparations; anti-fibrotic pharmaceutical preparations; pharmaceutical preparations for treatment and prevention of HIV infection; pharmaceutical preparations for the treatment of liver diseases and disorders; pharmaceutical preparations for the treatment of hematological diseases and disorders; pharmaceutical preparations for the treatment of oncological diseases and disorders; pharmaceutical preparations for the treatment of inflammatory diseases and disorders; pharmaceutical preparations for the treatment of autoimmune diseases and disorders; pharmaceutical preparations for the treatment of respiratory and pulmonary diseases and disorders; pharmaceutical preparations for the treatment of kidney and nephropathic diseases and disorders; pharmaceutical preparations for the treatment of arthritis

Publications

History of USPTO decisions and trademark events.

46 publications found

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

07/22/2026

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

07/22/2026

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

07/22/2026

CHAN

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

07/22/2026

COAR

TEAS CHANGE OF OWNER ADDRESS RECEIVED

07/22/2026

NRCC

NOTICE OF REGISTRATION CONFIRMATION EMAILED

02/14/2023

R.PR

REGISTERED-PRINCIPAL REGISTER

02/14/2023

DP1B

1(B) BASIS DELETED; PROCEED TO REGISTRATION

01/09/2023

IUCN

NOTICE OF ALLOWANCE CANCELLED

01/06/2023

D1BR

TEAS DELETE 1(B) BASIS RECEIVED

01/06/2023

EXRA

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

07/14/2022

EX5G

SOU EXTENSION 5 GRANTED

07/13/2022

AITU

CASE ASSIGNED TO INTENT TO USE PARALEGAL

07/13/2022

EXT5

SOU EXTENSION 5 FILED

06/29/2022

EEXT

SOU TEAS EXTENSION RECEIVED

06/29/2022

EXRA

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

01/22/2022

EX4G

SOU EXTENSION 4 GRANTED

01/20/2022

EXT4

SOU EXTENSION 4 FILED

01/20/2022

EEXT

SOU TEAS EXTENSION RECEIVED

01/20/2022

EXRA

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

07/14/2021

EX3G

SOU EXTENSION 3 GRANTED

07/12/2021

EXT3

SOU EXTENSION 3 FILED

07/12/2021

EEXT

SOU TEAS EXTENSION RECEIVED

07/12/2021

EXRA

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

12/24/2020

EX2G

SOU EXTENSION 2 GRANTED

12/22/2020

EXT2

SOU EXTENSION 2 FILED

12/22/2020

EEXT

SOU TEAS EXTENSION RECEIVED

12/22/2020

EXRA

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

06/27/2020

EX1G

SOU EXTENSION 1 GRANTED

06/25/2020

EXT1

SOU EXTENSION 1 FILED

06/25/2020

EEXT

SOU TEAS EXTENSION RECEIVED

06/25/2020

NOAM

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

02/25/2020

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

12/31/2019

PUBO

PUBLISHED FOR OPPOSITION

12/31/2019

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

12/11/2019

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

11/20/2019

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

11/18/2019

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

11/18/2019

ALIE

ASSIGNED TO LIE

11/15/2019

ERSI

TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED

11/08/2019

GNS3

NOTIFICATION OF LETTER OF SUSPENSION E-MAILED

07/15/2019

GNSL

LETTER OF SUSPENSION E-MAILED

07/15/2019

CNSL

SUSPENSION LETTER WRITTEN

07/15/2019

DOCK

ASSIGNED TO EXAMINER

07/08/2019

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

05/13/2019

NWAP

NEW APPLICATION ENTERED

04/30/2019

Continuous trademark protection

Get notified about every new filing that threatens FIBLECTEV or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.